NCT06001281View on ClinicalTrials.gov

Predictive Value of Soluble CD146 in Glioblastoma Patients

NARecruitingINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

January 30, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Glioblastoma
Interventions
OTHER

plasma collection

Plasma samples will be prospectively collected at relevant time points during patient treatment.

Trial Locations (1)

13005

RECRUITING

Service de Neuro-oncologie, Marseille

All Listed Sponsors
lead

Assistance Publique Hopitaux De Marseille

OTHER